Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1748-717X
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Pretreatment SUVmax predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy ; volume:9 ; number:1 ; day:30 ; month:1 ; year:2014 ; pages:1-6 ; date:12.2014
Radiation oncology ; 9, Heft 1 (30.1.2014), 1-6, 12.2014

Urheber
Horne, Zachary D.
Beteiligte Personen und Organisationen
Clump, David A.
Vargo, John A.
Shah, Samir
Beriwal, Sushil
Burton, Steven A.
Quinn, Annette E.
Schuchert, Matthew J.
Landreneau, Rodney J.
Christie, Neil A.
Luketich, James D.
Heron, Dwight E.
SpringerLink (Online service)

DOI
10.1186/1748-717X-9-41
URN
urn:nbn:de:1111-2016072620996
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:54 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Horne, Zachary D.
  • Clump, David A.
  • Vargo, John A.
  • Shah, Samir
  • Beriwal, Sushil
  • Burton, Steven A.
  • Quinn, Annette E.
  • Schuchert, Matthew J.
  • Landreneau, Rodney J.
  • Christie, Neil A.
  • Luketich, James D.
  • Heron, Dwight E.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry

Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry

Stereotactic ablative brachytherapy versus percutaneous microwave ablation for early-stage non-small cell lung cancer: a multicenter retrospective study

Stereotactic ablative brachytherapy versus percutaneous microwave ablation for early-stage non-small cell lung cancer: a multicenter retrospective study

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer

Association of neutrophil–lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy

Association of neutrophil–lymphocyte ratio with survival in peripheral early-stage non-small cell lung cancer after stereotactic body radiation therapy

Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch® patient registry

Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch® patient registry

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer

Impact of Choroidal Melanoma Characteristics on Progression-Free Survival in Patients Undergoing Hypofractionated Stereotactic Photon Radiotherapy

Impact of Choroidal Melanoma Characteristics on Progression-Free Survival in Patients Undergoing Hypofractionated Stereotactic Photon Radiotherapy

Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation

Stereotactic ablative radiotherapy for early-stage lung cancer following double lung transplantation

Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN study

Multi-omics integrative modelling for stereotactic body radiotherapy in early-stage non-small cell lung cancer: clinical trial protocol of the MONDRIAN study

Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy

Response criteria in solid tumors (PERCIST/RECIST) and SUVmax in early-stage non-small cell lung cancer patients treated with stereotactic body radiotherapy

Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial

Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial

Verbundene Objekte